We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted ... Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection. Show more
Ask ADVFN Intelligence (AI)
SILVER SPRING, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a leader in drug-eluting biomatrix products, today announced that it will release...
SILVER SPRING, Md., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a leader in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and...
EluPro eradicated bacteria commonly associated with cardiac implant-related infections in an established preclinical infection model SILVER SPRING, Md., Sept. 18, 2024 (GLOBE NEWSWIRE...
Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment SILVER SPRING, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a...
SILVER SPRING, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced a landmark achievement with the...
SILVER SPRING, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.08 | 2.5641025641 | 3.12 | 3.39 | 3.06 | 13988 | 3.24469867 | CS |
| 4 | -0.5248 | -14.089347079 | 3.7248 | 3.99 | 2.78 | 37213 | 3.44424825 | CS |
| 12 | 0.64 | 25 | 2.56 | 4.5 | 2.28 | 41522 | 3.75720749 | CS |
| 26 | 0.31 | 10.7266435986 | 2.89 | 5.24 | 2.28 | 56671 | 3.77650973 | CS |
| 52 | 2.005 | 167.782426778 | 1.195 | 5.24 | 1.17 | 43872 | 3.3512371 | CS |
| 156 | 2.01 | 168.907563025 | 1.19 | 5.24 | 1.1 | 132646 | 2.08974577 | CS |
| 260 | 2.01 | 168.907563025 | 1.19 | 5.24 | 1.1 | 132646 | 2.08974577 | CS |
Monksdream
2 weeks ago
Monksdream
4 months ago
TrendTrade2016
4 months ago
TrendTrade2016
4 months ago
TrendTrade2016
5 months ago
Monksdream
5 months ago
Monksdream
6 months ago
TrendTrade2016
9 months ago
Agoura Guy
9 months ago
TrendTrade2016
9 months ago
TrendTrade2016
10 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
